CR20150259A - Anticuerpos egfr/c-met biespecíficos - Google Patents

Anticuerpos egfr/c-met biespecíficos

Info

Publication number
CR20150259A
CR20150259A CR20150259A CR20150259A CR20150259A CR 20150259 A CR20150259 A CR 20150259A CR 20150259 A CR20150259 A CR 20150259A CR 20150259 A CR20150259 A CR 20150259A CR 20150259 A CR20150259 A CR 20150259A
Authority
CR
Costa Rica
Prior art keywords
met
biespecíficos
antibodies egfr
egfr
antibodies
Prior art date
Application number
CR20150259A
Other languages
English (en)
Inventor
Mark Chiu
Sheri Moores
Joost Neijssen
Paul Parren
Janine Schuurman
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/071288 external-priority patent/WO2014081954A1/en
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of CR20150259A publication Critical patent/CR20150259A/es

Links

Abstract

Anticuerpos EGFR/c-Met biespecíficos y métodos para hacer y usar las moléculas.
CR20150259A 2012-11-21 2015-05-15 Anticuerpos egfr/c-met biespecíficos CR20150259A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261728912P 2012-11-21 2012-11-21
US201361782550P 2013-03-14 2013-03-14
US201361809541P 2013-04-08 2013-04-08
PCT/US2013/071288 WO2014081954A1 (en) 2012-11-21 2013-11-21 BISPECIFIC EGFR/c-Met ANTIBODIES

Publications (1)

Publication Number Publication Date
CR20150259A true CR20150259A (es) 2015-08-14

Family

ID=54337482

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20150259A CR20150259A (es) 2012-11-21 2015-05-15 Anticuerpos egfr/c-met biespecíficos

Country Status (1)

Country Link
CR (1) CR20150259A (es)

Similar Documents

Publication Publication Date Title
CY1123550T1 (el) Διπλοειδικα egfr/c-met αντισωματα
CR20150046A (es) Anticuerpos anti-cd79b e inmunoconjugados
CR20150049A (es) Anticuerpos e inmunoconjugados anti-cd79b
CR20140441A (es) Anticuerpos anti-lgr5 e inmunoconjugados
CR20150482A (es) Anticuerpos e inmunoconjugados anti-b7-h4
EA201590993A1 (ru) Гетеродимерные иммуноглобулины
CR20150047A (es) Anticuerpos anti-cd22 e inmunoconjugados
CL2015002742A1 (es) Moléculas de unión para bcma y cd3.
UY34815A (es) Anticuerpos biespecíficos y sus métodos de uso
CR20150048A (es) Anticuerpos e inmunoconjugados anti-cd22
CR20130359A (es) Anticuerpos del cea
UY34885A (es) Proteínas de unión anti-mesotelina
UY34454A (es) Moléculas de unión para bcma y cd3
UY4153Q (es) Batería
BR112013024363A2 (pt) método, e aparelho
BR112014027219A2 (pt) método
DK2931748T3 (da) Bmp-6-antistoffer
AR097668A1 (es) Colorante-polímero
AR096154A1 (es) Colorantes bisazoicos alcoxilados
BR112015023782A2 (pt) conjunto de polias
EA201591720A1 (ru) Белки, специфические по отношению к baff и b7rp1, и их применение
UY4152Q (es) Batería
UY34127A (es) ?zapato con plantilla reconfigurable y método
BR112015025165A2 (pt) veículo
CR20150259A (es) Anticuerpos egfr/c-met biespecíficos